An Application Provides Personalized Suggestions Based on Secondary Prevention Risk Factors to Stroke Patients

Launched by XUANWU HOSPITAL, BEIJING · Jul 31, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new smartphone app designed to help people who have recently had an acute ischemic stroke, which is a type of stroke caused by a blockage in blood flow to the brain. The app gives personalized advice based on each patient’s risk factors to help reduce the chance of having another stroke. The study aims to see if using this app can actually lower the risk of stroke coming back.

People who might join this study are adults between 40 and 80 years old who have been diagnosed with an ischemic stroke within the past two weeks and live locally. Participants need to have a smartphone or similar device to use the app. The study is not yet recruiting patients, but those interested should be willing to follow the study instructions and sign a consent form. Some people won’t be eligible, such as those with other types of strokes, certain medical conditions, or cognitive problems that make it hard to participate. If you join, you will use the app, which will provide tailored suggestions to help manage your health and reduce stroke risk, and researchers will monitor how well this approach works.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 40 to 80, with no gender restrictions;
• • Acute ischemic stroke inpatients within 2 weeks of onset, where the onset time is the time when stroke symptoms appear or the last known normal time of the patient (when it is an onset during sleep or the symptom onset time cannot be accurately obtained due to aphasia, impaired consciousness, etc.);
• • Confirmed diagnosis of ischemic stroke by CT or MRI of the brain within 2 weeks after symptom onset; ④ Local residents (residing for ≥6 months); ⑤ Patients who voluntarily participate in the study, have high compliance, and can sign the informed consent form;
• • Patients who own a smartphone or other smart devices.
• Exclusion Criteria:
• • Patients diagnosed with other cerebrovascular diseases (hemorrhagic stroke, transient ischemic attack, cerebral venous sinus thrombosis, etc.) or non-cerebrovascular diseases;
• • Known pregnant or lactating women, or those who tested positive on a pregnancy test before cluster randomization;
• • Patients with other conditions that may affect participation in the trial (e.g., refractory hypertension, severe aphasia, etc.);
• • Patients undergoing psychiatric/psychological treatment that may contaminate the results; ⑤ Patients with a life expectancy of less than one year (e.g., coexisting malignant tumors, severe cardiopulmonary diseases, etc.);
• • Patients already participating in other interventional clinical studies that may influence the outcome assessment; ⑦ Patients for whom the investigator deems unsuitable for participation in this study or who may pose significant risks to the patients (e.g., cognitive impairment preventing understanding and/or compliance with the study procedures and/or follow-up).